Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Dystonia Management: What to Expect From the Future? The Perspectives of Patients and Clinicians Within DystoniaNet Europe

M. Smit, A. Albanese, M. Benson, MJ. Edwards, H. Graessner, M. Hutchinson, R. Jech, JK. Krauss, F. Morgante, B. Pérez Dueñas, RB. Reilly, M. Tinazzi, MF. Contarino, MAJ. Tijssen, Collaborative Working Group

. 2021 ; 12 (-) : 646841. [pub] 20210603

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21017616

Improved care for people with dystonia presents a number of challenges. Major gaps in knowledge exist with regard to how to optimize the diagnostic process, how to leverage discoveries in pathophysiology into biomarkers, and how to develop an evidence base for current and novel treatments. These challenges are made greater by the realization of the wide spectrum of symptoms and difficulties faced by people with dystonia, which go well-beyond motor symptoms. A network of clinicians, scientists, and patients could provide resources to facilitate information exchange at different levels, share mutual experiences, and support each other's innovative projects. In the past, collaborative initiatives have been launched, including the American Dystonia Coalition, the European Cooperation in Science and Technology (COST-which however only existed for a limited time), and the Dutch DystonieNet project. The European Reference Network on Rare Neurological Diseases includes dystonia among other rare conditions affecting the central nervous system in a dedicated stream. Currently, we aim to broaden the scope of these initiatives to a comprehensive European level by further expanding the DystoniaNet network, in close collaboration with the ERN-RND. In line with the ERN-RND, the mission of DystoniaNet Europe is to improve care and quality of life for people with dystonia by, among other endeavors, facilitating access to specialized care, overcoming the disparity in education of medical professionals, and serving as a solid platform to foster international clinical and research collaborations. In this review, both professionals within the dystonia field and patients and caregivers representing Dystonia Europe highlight important unsolved issues and promising new strategies and the role that a European network can play in activating them.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21017616
003      
CZ-PrNML
005      
20210729103950.0
007      
ta
008      
210726s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fneur.2021.646841 $2 doi
035    __
$a (PubMed)34149592
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Smit, Marenka $u Expertise Centre Movement Disorders Groningen, Department of Neurology, University Medical Centre Groningen, Groningen, Netherlands
245    10
$a Dystonia Management: What to Expect From the Future? The Perspectives of Patients and Clinicians Within DystoniaNet Europe / $c M. Smit, A. Albanese, M. Benson, MJ. Edwards, H. Graessner, M. Hutchinson, R. Jech, JK. Krauss, F. Morgante, B. Pérez Dueñas, RB. Reilly, M. Tinazzi, MF. Contarino, MAJ. Tijssen, Collaborative Working Group
520    9_
$a Improved care for people with dystonia presents a number of challenges. Major gaps in knowledge exist with regard to how to optimize the diagnostic process, how to leverage discoveries in pathophysiology into biomarkers, and how to develop an evidence base for current and novel treatments. These challenges are made greater by the realization of the wide spectrum of symptoms and difficulties faced by people with dystonia, which go well-beyond motor symptoms. A network of clinicians, scientists, and patients could provide resources to facilitate information exchange at different levels, share mutual experiences, and support each other's innovative projects. In the past, collaborative initiatives have been launched, including the American Dystonia Coalition, the European Cooperation in Science and Technology (COST-which however only existed for a limited time), and the Dutch DystonieNet project. The European Reference Network on Rare Neurological Diseases includes dystonia among other rare conditions affecting the central nervous system in a dedicated stream. Currently, we aim to broaden the scope of these initiatives to a comprehensive European level by further expanding the DystoniaNet network, in close collaboration with the ERN-RND. In line with the ERN-RND, the mission of DystoniaNet Europe is to improve care and quality of life for people with dystonia by, among other endeavors, facilitating access to specialized care, overcoming the disparity in education of medical professionals, and serving as a solid platform to foster international clinical and research collaborations. In this review, both professionals within the dystonia field and patients and caregivers representing Dystonia Europe highlight important unsolved issues and promising new strategies and the role that a European network can play in activating them.
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Albanese, Alberto $u Department of Neurology, Istituto di Ricovero e Cura a Carattere Scientifico Humanitas Research Hospital, Milan, Italy
700    1_
$a Benson, Monika $u Dystonia Europe, Brussels, Belgium
700    1_
$a Edwards, Mark J $u Neuroscience Research Centre, Institute of Molecular and Clinical Sciences, St George's University of London, London, United Kingdom
700    1_
$a Graessner, Holm $u Institute of Medical Genetics and Applied Genomics and Centre for Rare Diseases, University of Tübingen, Tübingen, Germany
700    1_
$a Hutchinson, Michael $u Department of Neurology, St. Vincent's University Hospital, Dublin, Ireland
700    1_
$a Jech, Robert $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University, Prague, Czechia
700    1_
$a Krauss, Joachim K $u Department of Neurosurgery, Medizinische Hochschule Hannover, Hanover, Germany
700    1_
$a Morgante, Francesca $u Neuroscience Research Centre, Institute of Molecular and Clinical Sciences, St George's University of London, London, United Kingdom $u Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
700    1_
$a Pérez Dueñas, Belen $u Pediatric Neurology Research Group, Hospital Vall d'Hebron-Institut de Recerca (VHIR), Barcelona, Spain
700    1_
$a Reilly, Richard B $u School of Medicine, Trinity College, The University of Dublin, Dublin, Ireland
700    1_
$a Tinazzi, Michele $u Department of Neuroscience, Biomedicine and Movement Science, University of Verona, Verona, Italy
700    1_
$a Contarino, Maria Fiorella $u Department of Neurology, Leiden University Medical Centre, Leiden, Netherlands $u Department of Neurology, Haga Teaching Hospital, The Hague, Netherlands
700    1_
$a Tijssen, Marina A J $u Expertise Centre Movement Disorders Groningen, Department of Neurology, University Medical Centre Groningen, Groningen, Netherlands
710    2_
$a Collaborative Working Group
773    0_
$w MED00174552 $t Frontiers in neurology $x 1664-2295 $g Roč. 12, č. - (2021), s. 646841
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34149592 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20210726 $b ABA008
991    __
$a 20210729103949 $b ABA008
999    __
$a ind $b bmc $g 1676359 $s 1138058
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 12 $c - $d 646841 $e 20210603 $i 1664-2295 $m Frontiers in neurology $n Front. neurol. $x MED00174552
LZP    __
$a Pubmed-20210726

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace